Cresco Labs Inc. (CSE:CL)
Canada · Delayed Price · Currency is CAD 1.300
-0.050 (-3.70%)
Mar 12, 2026, 3:59 PM EST
Cresco Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 655.85 | 724.34 | 756.06 | 824.93 | 805.68 | |
Revenue Growth (YoY) | -9.46% | -4.20% | -8.35% | 2.39% | 73.98% |
Cost of Revenue | 331.28 | 359.89 | 408.52 | 430.2 | 375.9 |
Gross Profit | 324.57 | 364.45 | 347.54 | 394.73 | 429.79 |
Selling, General & Admin | 227.28 | 233.07 | 247.08 | 309.86 | 276 |
Other Operating Expenses | - | - | - | - | 16 |
Operating Expenses | 247.45 | 254.84 | 282.01 | 330.5 | 313.6 |
Operating Income | 77.11 | 109.61 | 65.53 | 64.23 | 116.18 |
Interest Expense | -60.03 | -57.52 | -63.62 | -58.52 | -52.15 |
Interest & Investment Income | 3.75 | 2.92 | 2.8 | 0.68 | 0.94 |
Earnings From Equity Investments | - | - | - | - | -1.2 |
Currency Exchange Gain (Loss) | -0.62 | 1.04 | -0.3 | 0.93 | -1.23 |
Other Non Operating Income (Expenses) | 9.41 | -62.59 | -1.91 | -0.7 | 26.91 |
EBT Excluding Unusual Items | 29.62 | -6.54 | 2.5 | 6.62 | 89.46 |
Merger & Restructuring Charges | - | - | - | -5.47 | -27.64 |
Impairment of Goodwill | -75.31 | - | -50.86 | -117.02 | -215.55 |
Gain (Loss) on Sale of Investments | -0.07 | -0.07 | -0.41 | -4.59 | 1.29 |
Gain (Loss) on Sale of Assets | -2.37 | -0.68 | 0.76 | 12.31 | -1.11 |
Asset Writedown | -29.79 | -2.32 | -100.16 | -23.63 | -90.34 |
Other Unusual Items | -17.51 | -1 | 1.26 | 4.88 | -12.83 |
Pretax Income | -95.42 | -10.62 | -146.9 | -126.91 | -256.73 |
Income Tax Expense | 44.62 | 49.87 | 32.95 | 88.94 | 40.11 |
Earnings From Continuing Operations | -140.04 | -60.49 | -179.85 | -215.84 | -296.83 |
Minority Interest in Earnings | 4.64 | -13.95 | 4.33 | 3.8 | -22.76 |
Net Income | -135.41 | -74.44 | -175.52 | -212.05 | -319.6 |
Net Income to Common | -135.41 | -74.44 | -175.52 | -212.05 | -319.6 |
Shares Outstanding (Basic) | 355 | 345 | 324 | 298 | 262 |
Shares Outstanding (Diluted) | 355 | 345 | 324 | 298 | 262 |
Shares Change (YoY) | 2.76% | 6.69% | 8.61% | 13.66% | 24.64% |
EPS (Basic) | -0.38 | -0.22 | -0.54 | -0.71 | -1.22 |
EPS (Diluted) | -0.38 | -0.22 | -0.54 | -0.71 | -1.22 |
Free Cash Flow | 37.75 | 112.99 | 3.18 | -64.29 | -79.39 |
Free Cash Flow Per Share | 0.11 | 0.33 | 0.01 | -0.22 | -0.30 |
Gross Margin | 49.49% | 50.31% | 45.97% | 47.85% | 53.34% |
Operating Margin | 11.76% | 15.13% | 8.67% | 7.79% | 14.42% |
Profit Margin | -20.65% | -10.28% | -23.21% | -25.70% | -39.67% |
Free Cash Flow Margin | 5.76% | 15.60% | 0.42% | -7.79% | -9.85% |
EBITDA | 125.83 | 168.71 | 128.04 | 116.16 | 154.82 |
EBITDA Margin | 19.18% | 23.29% | 16.93% | 14.08% | 19.22% |
D&A For EBITDA | 48.71 | 59.1 | 62.51 | 51.93 | 38.64 |
EBIT | 77.11 | 109.61 | 65.53 | 64.23 | 116.18 |
EBIT Margin | 11.76% | 15.13% | 8.67% | 7.79% | 14.42% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.